YM-201636

CAT: 0804-HY-13228-01Size: 2 mgDry Ice: NoHazardous: No
CAT#:0804-HY-13228-01Size:2 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
YM-201636 is a potent and selective PIKfyve inhibitor with an IC50 of 33 nM. YM-201636 also inhibits p110α with an IC50 of 3.3 μM. YM-201636 inhibits retroviral replication.
CAS Number
[371942-69-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; Influenza Virus; PI3K; PIKfyve
Type
Reference compound
Related Pathways
Anti-infection; Autophagy; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/ym-201636.html
Purity
98.05
Solubility
DMSO : ≥ 47 mg/mL
Smiles
O=C(NC1=CC=CC(C2=NC(N3CCOCC3)=C4OC5=NC=CC=C5C4=N2)=C1)C6=CC=C(N=C6)N
Molecular Formula
C25H21N7O3
Molecular Weight
467.48
Precautions
H302, H315, H319, H335
References & Citations
[1]Jefferies HB, et al. A selective PIKfyve inhibitor blocks PtdIns (3,5) P (2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep, 2008, 9 (2), 164-170.|[2]Ikonomov OC, et al. YM-201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns (3,5) P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem Biophys Res Commun. 2009 May 8;382 (3) :566-70.|[3]Sbrissa D, et al. Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns (3,5) P2 by means of the PIKfyve inhibitor YM-201636. Am J Physiol Cell Physiol. 2012 Aug 15;303 (4) :C436-46.|[4]Dukes JD, et al. The PIKfyve inhibitor YM-201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS One. 2012;7 (3) :e28659.|[5]Ikonomov OC, et al. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns (3,5) P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem Biophys Res Commun. 2009 May 8;382 (3) :566-70.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα

Popular Products